PUBLISHED IN THE OFFICIAL JOURNAL OF THE PATENT OFFICE DATED – 09/09/2011
Sr. Application No. Title of the Invention Date of Applicant No. Application 1. 1538/DEL/2010 Sustained Release Dosage Form Of 01/07/2010 Singh Jagdeep Terminalia Arjuna Extract 2. 2771/CHE/2011 A Novel Composition For Curing 12/08/2011 Dr. K.Sumitra Endothelial Dysfunction In Diabetes 3. 2101/CHE/2011 A Novel Process For The 21/06/2011 Divi's Laboratories Ltd Preparation Of Bezedoxifene Acetate And Its Intermediates There Of 4. 3066 /DELNP/2010 Pharmaceutical Formulation Of 30/04/2010 Rexahn Pharmaceuticals, Clavulanic Acid Inc 5. 2624/DEL/2009 Herbal Composition Of Calcitriol 16/12/2009 Himalaya Global Holdings Enriched Extracts From Solanum Limited Species And Method For Preparing The Same 6. 497/DEL/2010 Topical Compositions Of 04/03/2010 Ranbaxy Laboratories Aceclofenac Limited 7. 506/DEL/2010 A Novel Salmonella Typhi Protein 05/03/2010 Indian Council Of Medical As Subunit Vaccine□ Research 8. 484/DEL/2010 In-Vitro Dissolution Method For 04/03/2010 Ranbaxy Laboratories Uniform And Sustained Release Of Limited Olanzapine 9. 6381/DELNP/2010 5imidazoquinolines And Pyrimidine 09/09/2010 Novartis Ag Derivatives As Potent Modulators Of VEGF-Driven Angiogenic Processes 10. 6373/DELNP/2010 Linear And Cyclic Guanidine 09/09/2010 Universita' Degli Studi Di Derivatives, Method Of Preparation Siena And Uses Thereof 11. 6348/DELNP/2010 Process For The Regioselective 08/09/2010 Bayer Cropscience Ag Synthesis Of L-Alkyl-3- Haloalkylpyrazole-4- Carboxylic Acid Derivatives 12. 6354/DELNP/2010 Bicyclic Nitroimidazoles Covalently 08/09/2010 Global Alliance For Tb Linked To Substituted Phenyl Drug Development Oxazolidinones 13. 6554/DELNP/2010 Bridged Heterocycles As HIV 17/09/2010 Bristol-Myers Squibb Integrase Inhibitors Company 14. 6369/DELNP/2010 Herbicidal Method 09/09/2010 Syngenta Participations Ag
1 Gopakumar Nair Associates
15. 6566/DELNP/2010 Modular Method To Prepare 17/09/2010 IBC Pharmaceuticals, Inc Tetrameric Cytokines With Improved Pharmacokinetics By The Dock-And-Lock (DNL) Technology 16. 6567/DELNP/2010 Total Synthesis Of Salinosporamide 17/09/2010 Nereus Pharmaceuticals, A And Analogs Thereof Inc. 17. 6568/DELNP/2010 Methods For Increasing Absorption 17/09/2010 Nestec S.A. Of Peptides, Peptidomimetics, And Other Gastrointestinal Transport Protein Substrates 18. 6551/DELNP/2010 Stabilized Oil-In-Water Emulsions 17/09/2010 Dow Agrosciences LLC Including Agriculturally Active Ingredients 19. 6587/DELNP/2 010 Protein Nanocarriers, Process For 20/09/2010 Kap Sid Link, S.L. Obtaining Them And Applications 20. 6588/DELNP/2010 Novel Compositions And Methods 20/09/2010 Genentech, Inc For The Treatment Of Immune Related Diseases 21. 6589/DELNP/2010 Nucleotide Sequences And 20/09/2010 Ceres, Inc. Corresponding Polypeptides Conferring Improved Nitrogen Use Efficiency Characteristics In Plants 22. 6612/DELNP/2010 New Chimeric Alpha-Amylase 20/09/2010 Danisco Us Inc Variants 23. 6605/DELNP/2010 Manufacture, Transport And 20/09/2010 Millikelvin Technologies Delivery Of Material Containing LLC. Highly Polarized Nuclei 24. 6624/DELNP/2010 Sustained Drug-Releasing Stent 20/09/2010 Japan Stent Technology Co., Ltd. 25. 6625/DELNP/2010 Method For Determining The Type 20/09/2010 Universitatsklinikum Of An Inflammatory-Rheumatic Freiburg Disease In Synovial Fluid 26. 6626/DELNP/2010 Mimotopes Of Alpha-Synuclein 20/09/2010 Affiris Ag And Vaccines Thereof For The Treatment Of Neurodegenerative Disorders 27. 6631/DELNP/2010 Hair Conditioning Composition 21/09/2010 Kao Corporation 28. 6614/DELNP/2010 Antibody Purification Process 20/09/2010 Novo Nordisk A/S 29. 6651/DELNP/2010 Use Of Ferritin To Treat Iron 21/09/2010 Chyna LLC Deficiency Disorders 30. 6662/DELNP/2010 Sustained Release Poloxamer 22/09/2010 Allergan Inc. Containing Pharmaceutical Compositions 31. 6652/DELNP/2010 Macrocyclic Prodrug Compounds 21/09/2010 Nexgenix Pharmaceuticals Useful As Therapeutics 32. 6656/DELNP/2010 Arylsulfonamide-Based Matrix 21/09/2010 Novartis Ag Metalloprotease Inhibitors
2 Gopakumar Nair Associates
33. 6657/DELNP/2010 Orally-Disintegrating Solid 21/09/2010 Takeda Pharmaceutical Preparation Company Limited 34. 6565/DELNP/2010 Novel Compounds Advantageous In 17/09/2010 Aurimmed Pharma, Inc The Treatment Of Central Nervous System Diseases And Disorders 35. 6716/DELNP/2010 Oral Care Composition Containing 23/09/2010 Danisco Us Inc. Oxidase Enzyme 36. 6682/DELNP/2010 Pest Control Using Natural Pest 22/09/2010 Tyratech, Inc. Control Agent Blends 37. 6738/DELNP/2010 Poly Aromatic Sodium Channel 24/09/2010 Parion Sciences, Inc. Blockers 38. 6739/DELNP/2010 Cyclic Alkylene Carbonate-Derived 24/09/2010 Bayer Materialscience Ag Isocyanate-Terminated Prepolymers, Method For Their Preparation And Their Use 39. 6740/DELNP/2010 Purified Immunoglobulin Fusion 24/09/2010 Biogen Idec Ma Inc Proteins And Methods Of Their Purification 40. 6742/DELNP/2010 Bombesin Analog Peptide 24/09/2010 Universitatsspital Basel Antagonist Conjugates 41. 6724/DELNP/2010 Preparation Of 6-Aminocaproic 23/09/2010 DSM IP Assets B. V. Acid From 5-Formyl Valeric Acid 42. 6725/DELNP/2010 Adipate Ester Or Thioester 23/09/2010 DSM IP Assets B. V. Synthesis 43. 6750/DELNP/2010 High Expression Zymomonas 24/09/2010 E. I. Du Pont De Nemours Promoters And Company 44. 6711/DELNP/2010 Carbohydrate Lactone Polymers 23/09/2010 Imperial Innovations Limited 45. 6746/DELNP/2010 Image-Guided Therapy Of 24/09/2010 The Board Of Regents Of Myocardial Disease: Composition, The University Of Manufacturing And Applications Texas System 46. 6784/DELNP/2010 Crystalline Form Of N-[[4-Fluoro-2- 27/09/2010 Bristol-Myers Squibb (5-Methyl-1h-1,2,4-Triazol-1- Company Yl)Phenyl]Methyl]-4,6,7,9- Tetrahydro-3-Hydroxy-9,9- Dimethyl-4-Oxo-Pyrimido[2,1-C] [1,4]Oxazine-2-Carboxamine, Sodium Salt Monohydrate 47. 6753/DELNP/2010 Novel Estrogen Receptor Ligands 24/09/2010 Karo Bio Ab 48. 6876/DELNP/2010 An Isolated Nucleic Acid 29/09/2010 Biogen Idec Ma Inc., 49. 6882/DELNP/2010 Stabilizing Lipid Compositions For 29/09/2010 Taro Pharmaceuticals Oral Pharmaceutical Agents North America, Inc 50. 6766/DELNP/2010 Swollenin Compositions And 24/09/2010 Danisco Us Inc. Methods Of Increasing The Efficiency Of A Cellulose
3 Gopakumar Nair Associates
51. 6768/DELNP/2010 Modulators Of The Prostacyclin 24/09/2010 Arena Pharmaceuticals, (PG12) Receptor Useful For The Inc. Treatment Of Disorders Related Thereto 52. 675 5/DELNP/2010 Method Of Purifying Dianhydrides, 24/09/2010 Sabic Innovative Plastics The Dianhydrides Formed Thereby, Ip B.V. And Polyetherimides Formed Therefrom 53. 6771/DELNP/2010 Mesenchymal Stem Cells And 24/09/2010 Bone Therapeutics S.A. Bone-Forming Cells 54. 6761/DELNP/2010 Affinity Matured Crig Variants 24/09/2010 Genentech, Inc 55. 6762/DELNP/2010 Pharmaceutical Composition With 24/09/2010 Novartis Ag Bisphosphona 56. 6903/DELNP/2010 Methods Of Treating Chronic Pain 30/09/2010 Pfizer Limited 57. 6906/DELNP/2 010 Substituted Enaminothiocarbonyl 30/09/2010 Bayer Cropscience Ag Compounds 58. 6930/DELNP/2010 Imidazo-Pyridine Derivatives As 30/09/2010 Novartis Ag Activin-Like Receptor Kinase (Alk4 Or Alk5) Inhibitors 59. 6931/DELNP/2010 Compositions And Methods For The 30/09/2010 University Of Preparation Of Nanoemulsions Massachusetts 60. 7007/DELNP/2010 Synergic 5'-Methylthioadenosine 04/10/2010 Proyecto De Biomedicina Combinations Cima, S.L. 61. 7008/DELNP/2010 A Block Copolymer And Polymer 04/10/2010 Kraton Polymers Us LLC Modified Bituminous Binder Composition For Use In Base Course Asphalt Paving Application 62. 6908/DELNP/2010 Methods For Producing Hair 30/09/2010 Technische Universitat Microfollicles And De Novo Berlin Papillae And Their Use For In Vitro Tests And In Vivo Implantations 63. 7014/DELNP/2010 Non-Invasive Systems And Methods 04/10/2010 Immunolight, LLC For In-Situ Photobiomodulation 64. 7010/DELNP/2010 Materials Having Embedded 04/10/2010 Bayer Cropscience Ag Insecticides And Additives 65. 7019/DELNP/2010 Process For Producing Isocyanates 04/10/2010 Asahi Kasei Chemicals Using Diaryl Carbonate Corporation 66. 7029/DELNP/2010 Methods And Materials For The 04/10/2010 Celonic Ag Reproducible Generation Of High Producer Cell Lines For Recombinant Proteins 67. 7035/DELNP/ 2010 Oral Compositions Comprising 04/10/2010 Colgate-Palmolive Shellac Wax And Bleached Shellac Company For Use In Stomatology And Dental Care 68. 7024/DELNP/2010 Compositions And Use Of Epasi 04/10/2010 Calando Pharmaceuticals, Inhibitors Inc.
4 Gopakumar Nair Associates
69. 7054/DELNP/ 2010 Process To Produce Fibrillar 05/10/2010 Academia Sinica Proteins And Method Of Treating Using Fibrillar Proteins 70. 6894/DELNP/2010 Compositions And Methods Of Use 30/09/2010 Bionumerik Of Compounds To Increase Cancer Pharmaceuticals, Inc Patient Survival Time 71. 6897/DELNP/2010 Liquid And Freeze Dried 30/09/2010 Ipsen Pharma S.A.S. Formulations 72. 7424/DELNP/2010 Novel Class Of Spiro Piperidines 21/10/2010 Pfizer Inc., For The Treatment Of Neurodegenerative Diseases 73. 7434/DELNP/2010 Neurodegenerative Disorders 21/10/2010 Amarantus Therapeutics, Inc. 74. 7436/DELNP/2010 Chemokine Receptor Modulators 21/10/2010 Altiris Therapeutics 75. 7453/DELNP/2010 Substituted Dihydropyrazolones As 22/10/2010 Bayer Schering Pharma Inhibitors Of HIF-Prolyl-4 Aktiengesellschaft Hydroxylases 76. 7456/DELNP/2010 Selective Subtype Alpha 2 22/10/2010 Allergan Inc. Adrenergic Agents And Methods For Use Thereof 77. 7471/DELNP/2010 Extracellular Scaffolds Comprising 22/10/2010 Universiti Malaya Blends Of Polyvinyl Alcohol And Carboxymethyl Chitosan 78. 7520/DELNP/2010 Hydroformylation Catalysts 26/10/2010 Eastman, Chemical Company 79. 7526/DELNP/2010 Pharmaceutical Composition For 26/10/2010 Momotaro-Gene Inc. Treating Or Preventing Cancer By Inducing Dendritic Cell-Like Differentiation From Monocytes To Improve Anticancer Immune Activity 80. 7554/DELNP/2010 Impaired Alleles Of Genes Involved 27/10/2010 The Regents Of The In Metabolic Pathways And University Of Methods For Detecting And Using California The Same 81. 7531/DELNP/2010 HER2/Neu-Specific Antibodies And 26/10/2010 Macrogenics, Inc. Methods Of Using Same 82. 7419/DELNP/2010 Purification Process For Antibody 21/10/2010 MSD Biologics (UK) Fragments Using Derivatized Limited Triazines As Affinity Ligands 83. 7590/DELNP/2010 Substituted Gamma Lactams As 28/10/2010 Allergan, Inc. Therapeutic Agents 84. 7606/DELNP/2010 Composition Comprising 28/10/2010 DSM IP Assets B. V. Carbohydrates And Peptides Which Comprise Tryptophan 85. 7565/DELNP/2010 The Use Of Solid Carrier Particles 27/10/2010 Gilead Sciences, Inc, To Improve The Process ability Of A Pharmaceutical Agent
5 Gopakumar Nair Associates
86. 7623/DELNP/2010 Spiro (Piperidine-4, 2'-Pyrrolidine)- 29/10/2010 Glaxo Wellcome 1-(3,5-Trifluoromethyl Phenyl) Manufacturing PTE Ltd. Methylcarboxamides As Nk1 Tachikynin Receptor Antagonists 87. 7613/DELNP/2010 Methods And Compositions For 28/10/2010 LS9, Inc., Producing Hydrocarbons 88. 7614/DELNP/2010 Methods And Compositions For 28/10/2010 LS9, Inc., Producing Hydrocarbons 89. 7599/DELNP/2010 Dried Formulations 28/10/2010 Zymes, LLC 90. 7645/DEL NP/2010 Thiazol-4-Carboxylic Acid Esters 29/10/2010 Bayer Cropscience Ag And Thioesters As Plant Protection Agents 91. 7646/DELNP/2010 Conjugates Of A Cholinesterase 29/10/2010 Nektar Therapeutics Moiety And A Polymer 92. 7650/DELNP/2010 Compositions And Methods For 29/10/2010 Ardea Biosciences, Inc. Preparing And Using Same 93. 7651/DELNP/2010 Oxo-Heterocyclic Substituted 29/10/2010 Bayer Schering Pharma Carboxylic Acid Derivatives And Aktiengesellschaft The Use Thereof 94. 7652/DELNP/2010 Nasal Formulations Of Insulin 29/10/2010 Cpex Pharmaceuticals, Inc. 95. 7657/DELNP/2010 Composition And Methods For 29/10/2010 Genentech, Inc. Treating And Diagnosing Asthma 96. 7668/DELNP/2010 Desaturase And Method For The 29/10/2010 Rothamsted Research Ltd. Production Of Polyunsaturated Fatty Acids In Transgenic Organisms 97. 7670/DELNP/2010 New Classes Of Gabaa/BZR 29/10/2010 Forskarpatent I Syd Ab Ligands 98. 7661/DELNP/2010 Permanent Delivery System And 29/10/2010 Altea Therapeutics Methods For Use Thereof Corporation, 99. 7662/DELNP/2 010 Tungsten Rhenium Compounds And 29/10/2010 Smith International, Inc., Composites And Methods For Forming The Same 100. 7665/DELNP/2010 New Peptidomimetic Compounds 29/10/2010 Almqvist, Fredrik 101. 7680/DELNP/2010 Compounds And Compositions As 29/10/2010 IRM LLC Protein Kinase Inhibitors 102. 7682/DELNP/2010 Improved Fibronectin-Based 29/10/2010 Novartis Ag Binding Molecules And Uses Thereof 103. 7683/DELNP/2010 Compounds And Compositions As 29/10/2010 IRM LLC Kinase Inhibitors 104. 7671/DELNP/2010 Gabaa Receptor Modulators 29/10/2010 Forskarpatent I Syd Ab 105. 7676/DELNP/2010 The Stabilisation Of Proteins 29/10/2010 Arecor Limited 106. 7677/DELNP/2010 Stable Formulation Of A 29/10/2010 Arecor Limited Therapeutic Protein 107. 8420/DELNP/2009 Clostridial Toxin Netb□ 22/12/2009 Australian Poultry CRC Pty Ltd
6 Gopakumar Nair Associates
108. 8456/DELNP/2009 Chiral Diachylhydrazine Ligands 23/12/2009 Intrexon Corporation For Modulating The Expression Of Exogenous Genes Via An Ecdysone Receptor Complex 109. 96/DELNP/2010 Proteinases Destroy Cancer Tumor's 06/01/2010 Biomedicure LLC Solid Structure And Kill Cancer Cells Locally 110. 8027/DELNP/2009 Treatment And Prevention Of 08/12/2009 Mat Malta Advanced Influenza□ Technologies Limited 111. 7636/DELNP/2010 Methods For Enhanced Production 29/10/2010 Wyeth LLC Of Bone Morphogenetic Proteins 112. 7638/DELNP/2010 Carbidopa/Lipodopa Gastroretentive 29/10/2010 Intec Pharma Ltd. Drug Delivery 113. 763 9/DELNP/2010 Quinolines And Related Analogs As 29/10/2010 Sirtris Pharmaceuticals, Sirtuin Modulators Inc. 114. 515/CHE/2010 Process For The Preparation Of 2- 01/03/2010 Msn Laboratories Limited ((4r,6s) - 6- ((E) -2- (4-(4- Fluorophenyl)-6-Isopropyl- 2-(N- Methylmethyl sulfonamido) Pyrimidin-5-Yl)Vinyl)-2,2- Dimethyl-1,3-Dioxan-4-Yl1)- N,N-Disubstituted acetamides 115. 561/CHE/2010 Poshaka: A Fortificant Formulation 04/03/2010 Karnataka State Sericulture To Enhance Cocoon Productivity Of Research & Development S Ilkworm Through Feed Institute Supplementation To Silkworm Larvae 116. 546/CHE/2010 Novel Salts Of 2-(5- ((Pyrrolidin - 1- 03/03/2010 Msn Laboratories Limited Ylsulfonyl) Methyl)-1h- Indol-3-Yl) Ethanamine And Their Use 117. 8043/CHENP/2010 Non-Hemolytic Clya For Excretion 10/12/2010 University Of Maryland Of Proteins□ Baltimore 118. 8050/CHENP/2010 Peptides For Targeting Apoptotic 13/12/2010 Kyungpook National Cells And Uses Thereof□ University Industry academic Cooperation Foundation 119. 8116/CHENP/2010 Plant-Based Compositions And 15/12/2010 Addevista Uses□ 120. 8201/CHENP/2010 Variants Of A Family 44 16/12/2010 Novozymes A/S Xyloglucanase 121. 8238/CHENP/2010 Recombinant Polyprotein Vaccines 17/12/2010 Infectious Disease For The Treatment And Diagnosis Research Institute Of Leishmaniasis□ 122. 81 76/CHENP/2010 Process For Preparing And Drying 15/12/2010 Teva Pharmaceutical Solid Rasagiline Base□ Industries Ltd. 123. 8293/CHENP/2010 Biomaterial Having A Latent Form 20/12/2010 Imperial Innovations Of Growth Factor□ Limited
7 Gopakumar Nair Associates
124. 8256/CHENP/2010 Cellular Differentiation Process And 20/12/2010 Universite Henri Poincare Its Use For Blood Vessel Build -Up Nancy 1 125. 8317/CHENP/2010 Compositions And Methods For 21/12/2010 Ambryx Biotechnology Increasing Serum Antioxidant Inc. Concentrations 126. 8295/CHENP/2010 Plants Having Enhanced Yield- 20/12/2010 Basf Plant Science GMBH Related Traits And A Method For Making The Same□ 127. 1867/KOLNP/2011 Crhr2 Peptide Agonists And Uses 04/05/2011 Janssen Pharmaceutica Nv Thereof 128. 1878/KOLNP/2011 Carbamate Derivatives Of Alkyl- 05/05/2011 Sanofi-Aventis Heterocycles, Preparation Thereof And Therapeutic Use Thereof 129. 1896/KOLNP/2011 Lantibiotic Carboxyamide 06/05/2011 Sentinella Pharmaceuticals, Derivatives With Enhanced Inc. (Sentinella) Antibacterial Activity 130. 1930/KOLNP/2011 Controlled-Release Microparticles 09/05/2011 Amorepacific Corporation And Method Of Preparing Same 131. 1925/KOLNP/2011 Component With An Antimicrobial 09/05/2011 Siemens Aktiengesellschaft Surface And Use Thereof 132. 1941/KOLNP/2011 (R)-3-(E)-2-(Pyrrolidin-3-Yl) 09/05/2011 Targacept, Inc Vinyl)-5-(Tetrahydropyran-4-Yloxy) Pyridine, Its Salts, Its Synthesis And Its Use As Ligand For Nicotinic Acetylcholinergic Receptors 133. 1942/KOLNP/2011 Synthesis Of Carbamoylpyridone 09/05/2011 Shionogi & Co., Ltd. HIV Integrase Inhibitors And Intermediates 134. 1943/KOLNP/2011 Novel Compounds 09/05/2011 Targacept, Inc. 135. 1947/KOLNP/2011 Novel Lipids And Compositions For 09/05/2011 Alnylam Pharmaceuticals, The Delivery Of Therapeutics Inc. 136. 1932/KOLNP/2011 Infusion Of Drugs 09/05/2011 Milux Holding Sa 137. 1934/KOLNP/2011 TCR Complex Immunotherapeutics 09/05/2011 Emergent Product Development Seattle, LLC 138. 1948/KOLNP/2011 Novel Lipids And Compositions For 09/05/2011 Alnylam Pharmaceuticals, The Delivery Of Therapeutics Inc 139. 1982/KOLNP/2011 Antitumor Combinations Containing 11/05/2011 Sanofi-Aventis Antibodies Recognizing Specifically CD38 And Cylophosphamide 140. 1990/KOLNP/2011 Antitumor Combinations Containing 11/05/2011 Sanofi-Aventis Antibodies Recognizing Specifically CD38 And Vincristine 141. 1991/KOLNP/2011 Intravaginal Delivery System And 11/05/2011 Bayer OY Process For Manufacturing It
8 Gopakumar Nair Associates